3 results
To determine the clinical performance of Elecsys® Troponin Ths Gen 6 relative to the clinical diagnosis at different time points after patient admission (T0, T1, T2, T3, T6) using the previously determined universal or combined sex-specific cut-off…
- The purpose of this study is to evaluate the efficacy of the study drug to lung function, exacerbations and quality of life with patients with COPD. The safety and tolerability of the study drug is monitored as part of this study.
This study compares upadacitinib to dupilumab in adolescent and adult participants with moderate to severe AD who have inadequate response to systemic therapies. Adverse events and change in the disease activity will be assessed.